This report is concerned with uncertainty as it affects the cost effectiveness aspects of health technology assessment (HTA). It includes a review of the policy documents governing cost benefit analysis and cost effectiveness analysis in respect of HTA in England and Wales, and the results of interviews with former decision makers at the National Institute for Health and Care Excellence (NICE).